About Contact Us Careers

Pharyngitis Treatment Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 3124
Published Date: Dec 23, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Pharyngitis Treatment Landscape

Teva Pharmaceutical Industries Ltd.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Viatris Inc. (Mylan)
Adamas Pharmaceuticals, Inc.
GlaxoSmithKline plc.
Abbott Laboratories
AbbVie Inc.
Amgen Inc.
Sanofi-aventis Groupe
Pfizer Inc.
Purdue Pharma L.P.

Browse Key Market Insights with Data Illustration:

Pharyngitis Treatment Market Size, Growth Forecasts 2037

In the News

May 04, 2021: Teva Pharmaceutical Industries Ltd. announced the launch of its new Erythromycin tablets to treat or prevent a variety of bacterial infections.

Author Credits: Radhika Pawar

Report ID: 3124
Published Date: Dec 23, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of pharyngitis treatment is evaluated at USD 2.39 billion.

Pharyngitis Treatment Market size was over USD 2.3 billion in 2024 and is poised to exceed USD 4.23 billion by 2037, witnessing over 4.8% CAGR during the forecast period i.e., between 2025-2037.

North America industry is poised to hold largest revenue share by 2037, impelled by high healthcare expenditure, highest health awareness among people, and increasing investment in R&D activities.

The major players in the market are GlaxoSmithKline plc., Abbott Laboratories, AbbVie Inc., Amgen Inc., Sanofi-aventis Groupe, Pfizer Inc., Purdue Pharma L.P., and others.

Inquiry Before Buying Request Free Sample